Arecor Therapeutics PLC Financial Flexibility Index
Arecor Therapeutics PLC financial flexibility index. Arecor Therapeutics PLC (AREC) has a Financial Flexibility Index of -0.70x as of December 2025. Free cash flow of GBX-1.15 Million (operating CF GBX-1.15 Million minus capex GBX1.00K) represents -1% of total liabilities (GBX1.65 Million).
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Arecor Therapeutics PLC (2018–2025)
Financial flexibility index of Arecor Therapeutics PLC from 2018 to 2025. Historical Financial Flexibility Index trend for Arecor Therapeutics PLC across 9 annual periods. Check AREC operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Arecor Therapeutics PLC Financial Flexibility Index by Year (2018–2025)
Arecor Therapeutics PLC financial flexibility index by year from 2018 to 2025. Year-by-year free cash flow to debt coverage for Arecor Therapeutics PLC. For the full cash flow conversion analysis, see Arecor Therapeutics PLC cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (GBX) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.33x | GBX-2.19 Million | GBX-2.29 Million | GBX1.65 Million | ▲ +50.9% |
| 2024 | -2.71x | GBX-9.13 Million | GBX-9.15 Million | GBX3.37 Million | ▼ -178.4% |
| 2023 | -0.97x | GBX-5.69 Million | GBX-5.84 Million | GBX5.85 Million | ▲ +59.8% |
| 2022 | -2.42x | GBX-10.44 Million | GBX-10.78 Million | GBX4.31 Million | ▼ -6.7% |
| 2021 | -2.27x | GBX-5.38 Million | GBX-5.45 Million | GBX2.37 Million | ▼ -341.3% |
| 2020 | -0.51x | GBX-1.80 Million | GBX-1.86 Million | GBX3.51 Million | ▼ -32.3% |
| 2019 | -0.39x | GBX-426.50K | GBX-458.80K | GBX1.10 Million | ▲ +80.3% |
| 2019 | -1.97x | GBX-2.43 Million | GBX-2.50 Million | GBX1.23 Million | ▼ -473.2% |
| 2018 | -0.34x | GBX-479.65K | GBX-492.57K | GBX1.40 Million | — |